tiprankstipranks
Trending News
More News >
Cartesian Therapeutics (RNAC)
NASDAQ:RNAC

Cartesian Therapeutics (RNAC) Revenue

Compare
1,141 Followers

Cartesian Therapeutics Revenue

Cartesian Therapeutics had a revenue of 452.00K in the quarter ending Sep 30, 2025, with 51.68%. This bring the company's revenue in the last twelve months to 1.09M, Decreased 6.34%. In the fiscal year ending Dec 31, 2024, Cartesian Therapeutics had annual revenue of 38.91M with 49.64% growth.
Revenue (ttm)
1.09M
Revenue Growth
P/S Ratio
4.46
Revenue/Employee
$589,591
Employees
66
Market Cap
$173.70M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
38.91M12.91M+149.64%
Dec 31, 2023
26.00M-84.77M+23.47%
Dec 31, 2022
110.78M25.70M+130.21%
Dec 31, 2021
85.08M68.48M+512.60%
Dec 31, 2020
16.60M9.92M+248.57%
Dec 31, 2019
6.68M5.77M+739.42%
Dec 31, 2018
903.00K696.00K+436.23%
Dec 31, 2017
207.00K-7.88M+2.56%
Dec 31, 2016
8.08M